Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 155,961 | 945 | N/A |
| Receivables | 339 | N/A | N/A |
| TOTAL | $156,840 | $968 | $N/A |
| Non-Current Assets | |||
| PPE Net | 1,328 | N/A | N/A |
| Intangibles | 454 | 509 | 0 |
| Other Non-Current Assets | 801 | 50 | 0 |
| TOTAL | $2,583 | $559 | $N/A |
| Total Assets | $159,423 | $1,527 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,584 | 211 | 0 |
| Accrued Expenses | 8,511 | 1,935 | N/A |
| Other current liabilities | 60 | N/A | N/A |
| TOTAL | $10,155 | $2,146 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 38,336 | N/A | N/A |
| Other Non-Current Liabilities | 770 | 621 | 0 |
| TOTAL | $113,871 | $85 | $N/A |
| Total Liabilities | $124,026 | $2,231 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 181 | 120 | N/A |
| Retained earnings | -33,906 | -8,403 | N/A |
| Other shareholders' equity | -35 | 6,411 | 0 |
| TOTAL | $-29,124 | $-704 | $N/A |
| Total Liabilities And Equity | $94,902 | $1,527 | $0 |